Skip to main content
. 2022 Aug 5;13:917584. doi: 10.3389/fgene.2022.917584

FIGURE 7.

FIGURE 7

The treatment sensitivity analysis of HCC clinical commonly used drugs in patients with different risk scores (A–I) Correlation and sensitivity between different risk scores and drug treatment effect; (A) Sorafenib; (B) Sunitinib; (C) Brivanib; (D) Doxorubicin; (E) 5-Fluorouracil; (F) Cisplatin; (G) Gemcitabine; (H) Erlotinib; (I) Camptothecin.